Skip to main content

Vanadis Core T21/T18/T13 Reagent Cartridge

Vanadis Core® qualitative assay for screening the risk of trisomy 21, 18, and/or 13.

Products may not be licenced in accordance with the laws in all countries, such as the United States. Please check with your local representative for availability.

Overview

Qualitative assay intended for an in vitro diagnostic use to act as an aid in screening for the risk of trisomy 21, 18, and/or 13 in fetus using cell-free DNA from pregnant women of at least 10 weeks of gestation.

Specifications

Application
Noninvasive Prenatal Testing (NIPT)
Brand
Vanadis Core®
Product Compatibility
Vanadis Core®
Scroll Icon